J. Tolar

J. Wagner, J. Tolar, S. Savage, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Synthetic zinc finger nuclease design and rapid assembly.

J. Tolar, B. Blazar, Mark J. Osborn, 2011, Human gene therapy.

Pharmacokinetics and Model-Based Dosing to Optimize Fludarabine Therapy in Pediatric Hematopoietic Cell Transplant Recipients.

V. Ivaturi, Tao Liu, S. Pai, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Pharmacokinetics of Clofarabine in Patients With High‐Risk Inherited Metabolic Disorders Undergoing Brain‐Sparing Hematopoietic Cell Transplantation

J. Tolar, P. Orchard, Jiayin Huang, 2011, Journal of clinical pharmacology.

Cross-genome knowledge-based expression data fusion

F. Zelezný, J. Tolar, J. Kléma, 2009 .

Current international perspectives on hematopoietic stem cell transplantation for inherited metabolic disorders.

J. Tolar, V. Prasad, C. Peters, 2010, Pediatric clinics of North America.

Immune regulatory cells in umbilical cord blood: T regulatory cells and mesenchymal stromal cells

J. Tolar, B. Blazar, K. Hippen, 2009, British journal of haematology.

The academic health center (AHC) chief academic officer (CAO) role in fostering interprofessional learning experiences

H. Davies, J. Tolar, K. Badr, 2019, Journal of Interprofessional Education & Practice.

From Mesoderm to Mesodermatology: Bone Marrow Mesenchymal Cells Heal Skin Wounds.

J. Tolar, Markéta Tolarová, 2015, Molecular therapy : the journal of the American Society of Gene Therapy.

Placenta-based therapies for the treatment of epidermolysis bullosa.

J. Tolar, C. Nevala-Plagemann, Catherine A. A. Lee, 2015, Cytotherapy.

Intrathecal enzyme replacement for Hurler syndrome: biomarker association with neurocognitive outcomes

E. I. Pierpont, J. Tolar, J. Eisengart, 2019, Genetics in Medicine.

Mesenchymal stromal cells for graft-versus-host disease.

J. Tolar, A. Keating, Pierre-Luc Villeneuve, 2011, Human gene therapy.

Phenotype categorization of neurofibromatosis type I and correlation to NF1 mutation types

Eun Key Kim, J. Tolar, H. Yoo, 2019, Journal of Human Genetics.

The host immune response is essential for the beneficial effect of adult stem cells after myocardial ischemia.

Jianyi(Jay) Zhang, J. Tolar, Xiaohong Wang, 2007, Experimental hematology.

Revertant Mosaicism in Epidermolysis Bullosa

J. Tolar, C. Ebens, Mark J. Osborn, 2022, Biomedicines.

Patient-specific naturally gene-reverted induced pluripotent stem cells in recessive dystrophic epidermolysis bullosa

J. Wagner, J. Tolar, J. McGrath, 2013, The Journal of investigative dermatology.

Concise Review: Transplantation of Human Hematopoietic Cells for Extracellular Matrix Protein Deficiency in Epidermolysis Bullosa

J. Wagner, J. Tolar, B. Blazar, 2011, Stem cells.

Hematopoietic Cell Transplantation for Fanconi Anemia

J. Wagner, J. Tolar, A. Auerbach, 2007 .

Sleeping Beauty transposon-mediated engineering of human primary T cells for therapy of CD19+ lymphoid malignancies.

J. Wagner, J. Tolar, B. Levine, 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

AWARD NUMBER: W81XWH-12-1-0609 TITLE: Stem Cell-Based Therapies for Epidermolysis Bullosa

J. Tolar, 2015 .

Preconditioning of mesenchymal stem cells for improved transplantation efficacy in recessive dystrophic epidermolysis bullosa

J. Tolar, J. McGrath, Christopher Perdoni, 2014, Stem Cell Research & Therapy.

Population Pharmacokinetics of Unbound Mycophenolic Acid in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplantation

J. Tolar, P. Orchard, P. Jacobson, 2012, Journal of clinical pharmacology.

Undergoing Allogeneic Hematopoietic Cell Transplantation Population Pharmacokinetics of Unbound Mycophenolic Acid in Pediatric and Young Adult Patients

J. Tolar, P. Orchard, P. Jacobson, 2012 .

Higher Mycophenolate Dose Requirements in Children Undergoing Hematopoietic Cell Transplant (HCT)

J. Tolar, P. Orchard, P. Jacobson, 2008, Journal of clinical pharmacology.

Adeno-Associated Virus–Mediated Delivery of a Mutant Endostatin in Combination with Carboplatin Treatment Inhibits Orthotopic Growth of Ovarian Cancer and Improves Long-term Survival

J. Tolar, B. Blazar, S. Ramakrishnan, 2006 .

The Minnesota mobile extracorporeal cardiopulmonary resuscitation consortium for treatment of out-of-hospital refractory ventricular fibrillation: Program description, performance, and outcomes

Casey M. Woster, T. Aufderheide, J. Tolar, 2020, EClinicalMedicine.

T cell progenitor therapy-facilitated thymopoiesis depends upon thymic input and continued thymic microenvironment interaction.

Jason S. Mitchell, J. Tolar, K. Hogquist, 2017, JCI insight.

Leading edge: emerging drug, cell, and gene therapies for junctional epidermolysis bullosa

J. Tolar, C. Ebens, A. Keith, 2020, Expert opinion on biological therapy.

Osteopetrosis with Micro-lacunar Resorption due to Defective Integrin Organization

J. Tolar, P. Vezzoni, H. Blair, 2009, Laboratory Investigation.

Incorporation of Immune Checkpoint Blockade into Chimeric Antigen Receptor T Cells (CAR-Ts): Combination or Built-In CAR-T

J. Tolar, C. Kim, Mark J. Osborn, 2018, International journal of molecular sciences.

Cross platform analysis of methylation, miRNA and stem cell gene expression data in germ cell tumors highlights characteristic differences by tumor histology

J. Tolar, K. Silverstein, A. J. Hooten, 2015, BMC Cancer.

Engraftment of Reprogrammed Human Bile Duct Cells Transiently Rescues Diabetes in Mice

J. Dutton, J. Tolar, C. Flory, 2018 .

Keratinocytes from Induced Pluripotent Stem Cells in Junctional Epidermolysis Bullosa

J Wagner, J. Wagner, J. Tolar, 2012, The Journal of investigative dermatology.

Contribution of the innate and adaptive immune systems to aortic dilation in murine mucopolysaccharidosis type I.

J. Tolar, M. G. O’Sullivan, D. Seelig, 2022, Molecular genetics and metabolism.

Elevated Cerebral Spinal Fluid Cytokine Levels in Boys with Cerebral Adrenoleukodystrophy Correlates with MRI Severity

G. Raymond, J. Tolar, A. Panoskaltsis-Mortari, 2012, PloS one.

Early diagnosis of cerebral X-linked adrenoleukodystrophy in boys with Addison’s disease improves survival and neurological outcomes

J. Tolar, S. Rothman, D. Nascene, 2011, European Journal of Pediatrics.

Chitotriosidase as a biomarker of cerebral adrenoleukodystrophy

G. Raymond, J. Tolar, S. Rothman, 2011, Journal of Neuroinflammation.

N-acetyl-L-cysteine improves outcome of advanced cerebral adrenoleukodystrophy

J. Tolar, P. Orchard, L. Charnas, 2007, Bone Marrow Transplantation.

An irradiated marrow niche reveals a small non-collagenous protein mediator of homing, dermatopontin.

D. K. Wood, Beau R. Webber, J. Tolar, 2021, Blood advances.

Heparin Enhances Transfection in Concert with a Trehalose-Based Polycation with Challenging Cell Types.

J. Tolar, T. Reineke, W. S. Boyle, 2017, Biomacromolecules.

Hematopoietic differentiation of induced pluripotent stem cells from patients with mucopolysaccharidosis type I (Hurler syndrome).

Beau R. Webber, G. Daley, M. Kyba, 2011, Blood.

Combination of enzyme replacement and hematopoietic stem cell transplantation as therapy for Hurler syndrome

J. Tolar, P. Orchard, L. Charnas, 2008, Bone Marrow Transplantation.

Hematopoietic cell therapy for metabolic disease.

J. Wagner, J. Tolar, B. Blazar, 2007, The Journal of pediatrics.

Cardiac Functional and Histopathologic Findings in Humans and Mice with Mucopolysaccharidosis Type I: Implications for Assessment of Therapeutic Interventions in Hurler Syndrome

J. Tolar, J. Berry, B. Blazar, 2006, Pediatric Research.

GVHD-associated, inflammasome-mediated loss of function in adoptively transferred myeloid-derived suppressor cells.

D. Munn, J. Tolar, J. Serody, 2015, Blood.

Thymic Epithelial Cell Support of Thymopoiesis Does Not Require Klotho

J. Tolar, D. Min, K. Weinberg, 2018, The Journal of Immunology.

T cells for the inhibition of graft-versus-host disease (GVHD) Insights into the mechanism of FTY720 and compatibility with regulatory

J. Tolar, J. Serody, V. Brinkmann, 2013 .

Insights into the mechanism of FTY720 and compatibility with regulatory T cells for the inhibition of graft-versus-host disease (GVHD).

J. Tolar, J. Serody, V. Brinkmann, 2007, Blood.

GVHD-associated , in fl ammasome-mediated loss of function in adoptively transferred myeloid-derived suppressor cells

D. Munn, J. Tolar, J. Serody, 2015 .

Healthcare access, satisfaction, and health-related quality of life among children and adults with rare diseases

Kathleen R. Bogart, J. Tolar, B. Joers, 2022, Orphanet Journal of Rare Diseases.

Inhibiting retinoic acid signaling ameliorates graft-versus-host disease by modifying T-cell differentiation and intestinal migration.

E. Dmitrovsky, D. Munn, J. Tolar, 2013, Blood.

Depletion of endogenous tumor-associated regulatory T cells improves the efficacy of adoptive cytotoxic T-cell immunotherapy in murine acute myeloid leukemia.

D. Munn, J. Tolar, B. Levine, 2009, Blood.

A homozygous frameshift variant in the KRT5 gene is compatible with life and results in severe recessive epidermolysis bullosa simplex

J. Tolar, C. Ebens, D. Keene, 2019, JAAD case reports.

HEMATOPOIESIS AND STEM CELLS DNA methylation of Runx1 regulatory regions correlates with transition from primitive to de ﬁ nitive hematopoietic potential in vitro and in vivo

Beau R. Webber, M. Kyba, M. Iacovino, 2013 .

A living band-aid for epidermolysis bullosa.

J. Tolar, M. Tolar, 2015, Blood transfusion = Trasfusione del sangue.

Peripheral neuro-immune pathology in recessive dystrophic epidermolysis bullosa

J. Tolar, G. Wendelschafer‐Crabb, W. Kennedy, 2014, The Journal of investigative dermatology.

IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced Function

J. Tolar, Bin Zhang, Jeffrey S. Miller, 2016, Clinical Cancer Research.

Dyskeratosis congenita: The first NIH clinical research workshop

M. Greene, J. Tolar, S. Savage, 2009, Pediatric blood & cancer.

Mesenchymal stromal cells from donors varying widely in age are of equal cellular fitness after in vitro expansion under hypoxic conditions.

J. Tolar, B. Blazar, T. Lund, 2010, Cytotherapy.

MSC Therapy Attenuates Obliterative Bronchiolitis after Murine Bone Marrow Transplant

Trevor J. Larsen, J. Tolar, M. Hertz, 2014, PloS one.

P63 targeted deletion under the FOXN1 promoter disrupts pre-and post-natal thymus development, function and maintenance as well as induces severe hair loss

J. Tolar, A. Mills, Yan Xing, 2022, PloS one.

Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita.

P. Rosenberg, H. Deeg, J. Tolar, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Chimerism and tolerance in a recipient of a deceased-donor liver transplant.

J. Tolar, T. Lund, 2008, The New England journal of medicine.

Expression of Telomerase and Telomere Length Are Unaffected by either Age or Limb Regeneration in Danio rerio

J. Tolar, Tiffany J Glass, B. Blazar, 2009, PloS one.

Bone marrow transplant with post‐transplant cyclophosphamide for recessive dystrophic epidermolysis bullosa expands the related donor pool and permits tolerance of nonhaematopoietic cellular grafts

J. Wagner, J. Tolar, J. McGrath, 2019, The British journal of dermatology.

Multipotent adult progenitor cells can suppress graft-versus-host disease via prostaglandin E2 synthesis and only if localized to sites of allopriming.

J. Tolar, B. Blazar, P. Taylor, 2009, Blood.

Host factors that impact the biodistribution and persistence of multipotent adult progenitor cells.

M. Kay, J. Tolar, C. Verfaillie, 2006, Blood.

Real-time in vivo imaging of stem cells following transgenesis by transposition.

M. Kay, J. Tolar, C. Contag, 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

TCIRG1 Transgenic Rescue of Osteoclast Function Using Induced Pluripotent Stem Cells Derived from Patients with Infantile Malignant Autosomal Recessive Osteopetrosis.

J. Tolar, C. Eide, Weili Chen, 2019, The Journal of bone and joint surgery. American volume.

Program death-1 (PD-1) signaling and regulatory T cells (Tregs) collaborate to resist the function of adoptively transferred cytotoxic T lymphocytes (CTLs) in advanced acute myeloid leukemia (AML) Running title: PD-1 blockade and adoptive CTL therapy for AML

D. Munn, J. Tolar, C. June, 2010 .

multipotent adult progenitor cells Host factors that impact the biodistribution and persistence of

M. Kay, J. Tolar, C. Verfaillie, 2013 .

Long-term metabolic, endocrine, and neuropsychological outcome of hematopoietic cell transplantation for Wolman disease

J. Tolar, J. Jessurun, P. Orchard, 2009, Bone Marrow Transplantation.

A 3D in vitro model of the dermoepidermal junction amenable to mechanical testing

Jangwook P. Jung, J. Tolar, Wei-han Lin, 2018, Journal of biomedical materials research. Part A.

Optimization of therapy for severe aplastic anemia based on clinical, biologic, and treatment response parameters: conclusions of an international working group on severe aplastic anemia convened by the Blood and Marrow Transplant Clinical Trials Network, March 2010.

H. Deeg, J. Tolar, S. Savage, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy.

R. Collins, H. Deeg, S. Feig, 2006, Blood.

Alternative donor transplant of benign primary hematologic disorders

J. Tolar, P. Sodani, H. Symons, 2015, Bone Marrow Transplantation.

Correction of Fanconi Anemia Mutations Using Digital Genome Engineering

Walker S. Lahr, Beau R. Webber, Mitchell G. Kluesner, 2022, International journal of molecular sciences.

Characterization and management of hypercalcemia following transplantation for osteopetrosis

J. Tolar, C. Martinez, P. Orchard, 2010, Bone Marrow Transplantation.

Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): a phase 2, single centre, open-label, randomised controlled trial

T. Aufderheide, J. Tolar, M. Biros, 2020, The Lancet.

Late Effects Screening Guidelines after Hematopoietic Cell Transplantation for Inherited Bone Marrow Failure Syndromes: Consensus Statement From the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects After Pediatric HCT.

J. Wagner, J. Tolar, S. Savage, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Preclinical Testing of Antihuman CD28 Fab′ Antibody in a Novel Nonhuman Primate Small Animal Rodent Model of Xenogenic Graft-Versus-Host Disease

J. Tolar, B. Blazar, V. Tkachev, 2016, Transplantation.

Transplant outcomes in leukodystrophies.

J. Tolar, P. Orchard, 2010, Seminars in hematology.

Pharmacologic properties of high-dose ambroxol in four patients with Gaucher disease and myoclonic epilepsy

J. Tolar, A. Rolfs, H. Yoo, 2019, Journal of Medical Genetics.

ABCB5+ dermal mesenchymal stromal cells with favorable skin homing and local immunomodulation for recessive dystrophic epidermolysis bullosa treatment

J. Tolar, C. Ebens, C. Eide, 2021, Stem cells.

Murine chronic graft-versus-host disease proteome profiling discovers CCL15 as a novel biomarker in patients.

Nathan H. Roy, Philip R. Gafken, Y. Ogata, 2018, Blood.

Clear cells in the atrioventricular valves of infants with severe human mucopolysaccharidosis (Hurler syndrome) are activated valvular interstitial cells.

J. Tolar, F. Schoen, W. Krivit, 2011, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

Lipid Composition of Whole Brain and Cerebellum in Hurler Syndrome (MPS IH) Mice

J. Tolar, T. Seyfried, B. Blazar, 2011, Neurochemical Research.

Impaired Mitochondrial and Metabolic Function of Fibroblasts Derived from Patients with Recessive Dystrophic and Junctional Epidermolysis Bullosa

J. Tolar, C. Eide, P. Crawford, 2020, EMJ Dermatology.

Gene therapy for Fanconi anemia: one step closer to the clinic.

J. Tolar, J. Bueren, H. Hanenberg, 2012, Human Gene Therapy.

Bone Marrow Stromal and Vascular Smooth Muscle Cells Have Chemosensory Capacity via Bitter Taste Receptor Expression

J. Tolar, D. Lidke, B. Blazar, 2013, PloS one.

Expansion and homing of adoptively transferred human natural killer cells in immunodeficient mice varies with product preparation and in vivo cytokine administration: implications for clinical therapy.

J. Wagner, J. Tolar, C. Rooney, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Zebrafish stromal cells have endothelial properties and support hematopoietic cells.

J. Tolar, Tiffany J Glass, B. Blazar, 2012, Experimental hematology.

MSCs for graft-versus-host disease

J. Tolar, B. Blazar, K. Blanc, 2013 .

Engraftment and survival following hematopoietic stem cell transplantation for osteopetrosis using a reduced intensity conditioning regimen

J. Tolar, P. Orchard, C. Bonfim, 2006, Bone Marrow Transplantation.

Accumulation of senescence observed in spinocerebellar ataxia type 7 mouse model

H. Orr, J. Tolar, D. Seelig, 2022, PloS one.

Gender Dimorphism in Aortic Insufficiency in Murine Mucopolysaccharidosis Type I

J. Tolar, B. Blazar, P. Orchard, 2013 .

Evolution of an adenine base editor into a small, efficient cytosine base editor with low off-target activity

Tony P. Huang, Gregory A. Newby, Jordan L. Doman, 2022, Nature Biotechnology.

Dual JAK2/Aurora kinase A inhibition prevents human skin graft rejection by allo‐inactivation and ILC2‐mediated tissue repair

J. Tolar, S. Sebti, J. Pidala, 2021, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

University of Dundee Lysyl hydroxylase 3 localizes to epidermal basement membrane and Is reduced in patients with Recessive Dystrophic Epidermolysis

J. Tolar, J. R. McMillan, J. McGrath, 2017 .

Lysyl Hydroxylase 3 Localizes to Epidermal Basement Membrane and Is Reduced in Patients with Recessive Dystrophic Epidermolysis Bullosa

J. Tolar, J. R. McMillan, J. McGrath, 2015, PloS one.

Non-myeloablative conditioning for second hematopoietic cell transplantation for graft failure in patients with non-malignant disorders: a prospective study and review of the literature

J. Tolar, P. Orchard, T. Lund, 2017, Bone Marrow Transplantation.

Second allogeneic hematopoietic cell transplantation for graft failure: Poor outcomes for neutropenic graft failure

J. Wagner, J. Tolar, D. Weisdorf, 2015, American journal of hematology.

Hematopoietic cell transplantation for nonmalignant disorders.

J. Tolar, P. Mehta, M. Walters, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Analysis of glycosaminoglycans in cerebrospinal fluid from patients with mucopolysaccharidoses by isotope-dilution ultra-performance liquid chromatography-tandem mass spectrometry.

J. Tolar, D. Millington, P. Orchard, 2011, Clinical chemistry.

Stem cell gene therapy for fanconi anemia: report from the 1st international Fanconi anemia gene therapy working group meeting.

David A. Williams, C. von Kalle, J. Wagner, 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

Alternate Donor HCT for Fanconi Anemia (FA): Results of a Total Body Irradiation (TBI) Dose De-Escalation Study

J. Wagner, J. Tolar, M. MacMillan, 2009 .

Alternate Donor HSCT for Fanconi Anemia (FA): Results of a Total Body Irradiation (TBI) Dose De-Escalation Study.

J. Wagner, J. Tolar, M. MacMillan, 2007 .

Response of refractory immune thrombocytopenia after bone marrow transplantation to romiplostim

J. Tolar, M. Burke, J. Beck, 2010, Pediatric blood & cancer.

Ternary Composite Nanofibers Containing Chondroitin Sulfate Scavenge Inflammatory Chemokines from Solution and Prohibit Squamous Cell Carcinoma Migration.

J. Tolar, K. Lozano, T. Reineke, 2019, ACS applied bio materials.

Lymphoproliferative disorder presenting as pulmonary nodules after bone marrow transplantation

J. Tolar, C. Peters, N. Ramsay, 2001, Bone Marrow Transplantation.

Rapid generation of Col7a1−/− mouse model of recessive dystrophic epidermolysis bullosa and partial rescue via immunosuppressive dermal mesenchymal stem cells

Beau R. Webber, J. Tolar, B. Moriarity, 2017, Laboratory Investigation.

Optimal Xenogeneic Adoptive Transfer of Human NK Cells: Fresh NK Cells and IL-15 Administration Are Superior to Frozen NK Cells and IL-2

J. Wagner, J. Tolar, C. Rooney, 2012 .

Osteopetrosis.

J. Tolar, S. Teitelbaum, P. Orchard, 2004, The New England journal of medicine.

Translating genome engineering to better clinical outcomes.

J. Tolar, 2013, Translational research : the journal of laboratory and clinical medicine.

Toxic Epidermal Necrolysis in Recessive Dystrophic Epidermolysis Bullosa following Bone Marrow Transplantation.

J. Wagner, J. Tolar, Sara A. Hylwa, 2016, The Journal of pediatrics.

P Toxic Epidermal Necrolysis in Recessive Dystrophic Epidermolysis Bullosa following Bone Marrow Transplantation

J. Wagner, J. Tolar, Sara A. Hylwa, 2016 .

From marrow to matrix: novel gene and cell therapies for epidermolysis bullosa.

Jakub Tolar, Beau R. Webber, J. Tolar, 2015, Molecular therapy : the journal of the American Society of Gene Therapy.

Outcome of haematopoietic stem cell transplantation in dyskeratosis congenita

S. Iacobelli, J. Tolar, P. Veys, 2018, British journal of haematology.

Semi-dominant GPNMB mutations in amyloidosis cutis dyschromica.

M. Simpson, J. Tolar, J. McGrath, 2019, The Journal of investigative dermatology.

Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation.

J. Wagner, J. Tolar, D. Weisdorf, 2006, Blood.

Long-term outcome of Hurler syndrome patients after hematopoietic cell transplantation: an international multicenter study.

A. Fischer, J. Tolar, J. Kurtzberg, 2015, Blood.

Outcome of penetrating keratoplasty for mucopolysaccharidoses.

C. Summers, J. Tolar, P. Orchard, 2011, Archives of ophthalmology.

Amelioration of epidermolysis bullosa by transfer of wild-type bone marrow cells.

J. Wagner, J. Tolar, J. Uitto, 2009, Blood.

A novel explanation of corneal clouding in a bone marrow transplant-treated patient with Hurler syndrome.

J. Tolar, D. Hardten, L. McLoon, 2016, Experimental eye research.

Outcomes of transplantation using various hematopoietic cell sources in children with Hurler syndrome after myeloablative conditioning.

A. Fischer, J. Tolar, J. Kurtzberg, 2013, Blood.

Hematopoietic stem cell transplantation for metabolic storage diseases

J. Tolar, P. Orchard, K. Baker, 2010 .

Post-transplant laronidase augmentation for children with Hurler syndrome: biochemical outcomes

J. Tolar, M. Pasquali, B. Bigger, 2019, Scientific Reports.

Clinical trial of laronidase in Hurler syndrome after hematopoietic cell transplantation

J. Tolar, J. Eisengart, P. Orchard, 2019, Pediatric Research.

Enzyme replacement therapy prior to haematopoietic stem cell transplantation in Mucopolysaccharidosis Type I: 10 year combined experience of 2 centres.

J. Tolar, B. Bigger, P. Orchard, 2016, Molecular genetics and metabolism.

Long-Term Cognitive and Functional Outcomes in Children with Mucopolysaccharidosis (MPS)-IH (Hurler Syndrome) Treated with Hematopoietic Cell Transplantation.

J. Tolar, K. Rudser, J. E. Wraith, 2016, JIMD reports.

Enzyme replacement is associated with better cognitive outcomes after transplant in Hurler syndrome.

J. Tolar, J. Eisengart, K. Rudser, 2013, The Journal of pediatrics.

An exploratory study of brain function and structure in mucopolysaccharidosis type I: long term observations following hematopoietic cell transplantation (HCT).

K. Thomas, J. Provenzale, J. Tolar, 2012, Molecular genetics and metabolism.

α-L-iduronidase therapy for mucopolysaccharidosis type I

J. Tolar, P. Orchard, 2008, Biologics : targets & therapy.

Short-term growth hormone treatment in children with Hurler syndrome after hematopoietic cell transplantation

James D. Schwender, J. Tolar, W. Thomas, 2009, Bone Marrow Transplantation.

Growth and endocrine function in patients with Hurler syndrome after hematopoietic stem cell transplantation

J. Tolar, J. Himes, P. Orchard, 2008, Bone Marrow Transplantation.

Cardiac Ultrasound Findings in Infants with Severe (Hurler Phenotype) Untreated Mucopolysaccharidosis (MPS) Type I.

J. Tolar, J. Berry, P. Orchard, 2013, JIMD reports.

Disruption of HIV-1 Co-Receptors CCR5 and CXCR4 in Primary Human T Cells and Hematopoietic Stem and Progenitor Cells Using Base Editing.

David R. Liu, Gregory A. Newby, Anton P. McCaffrey, 2021, Molecular therapy : the journal of the American Society of Gene Therapy.

Abnormal polyamine metabolism is unique to the neuropathic forms of MPS: potential for biomarker development and insight into pathogenesis

J. Tolar, James M. Wilson, C. Mesaros, 2017, Human molecular genetics.

Clinical trial of ABCB5+ mesenchymal stem cells for recessive dystrophic epidermolysis bullosa

J. Tolar, J. McGrath, C. Ebens, 2021, JCI insight.

Advances in understanding and treating dystrophic epidermolysis bullosa

J. Tolar, M. V. Vanden Oever, M. Vanden Oever, 2014, F1000prime reports.

Bone marrow transplantation for recessive dystrophic epidermolysis bullosa.

Jakub Tolar, John E Wagner, Mei Chen, 2010, The New England journal of medicine.

Role of transforming growth factor‐β1 in recessive dystrophic epidermolysis bullosa squamous cell carcinoma

J. Tolar, Weili Chen, K. Twaroski, 2021, Experimental dermatology.

Gene editing toward the use of autologous therapies in recessive dystrophic epidermolysis bullosa.

J. Tolar, Mark J. Osborn, Christopher J Perdoni, 2016, Translational research : the journal of laboratory and clinical medicine.

Sarcoma Derived from Cultured Mesenchymal Stem Cells

M. Kay, J. Tolar, P. Hogendoorn, 2007, Stem cells.

Large Intragenic Deletion in DSTYK Underlies Autosomal-Recessive Complicated Spastic Paraparesis, SPG23.

M. Simpson, S. Blumen, J. Tolar, 2017, American journal of human genetics.

Evaluation of TCR Gene Editing Achieved by TALENs, CRISPR/Cas9, and megaTAL Nucleases.

Christof von Kalle, Jakub Tolar, Richard Gabriel, 2016, Molecular therapy : the journal of the American Society of Gene Therapy.

Continuous treatment with IL-15 exhausts human NK cells via a metabolic defect.

J. Tolar, Jeffrey S. Miller, B. Blazar, 2018, JCI insight.

Rapid Induction of Cerebral Organoids From Human Induced Pluripotent Stem Cells Using a Chemically Defined Hydrogel and Defined Cell Culture Medium

Carolyn M. Scott, S. Keirstead, J. Dutton, 2016, Stem cells translational medicine.

Stable gene transfer and expression in human primary T cells by the Sleeping Beauty transposon system.

J. Tolar, B. Levine, C. June, 2005, Blood.

Transplacental and other routes of cancer transmission between individuals.

J. Tolar, J. Neglia, 2003, Journal of pediatric hematology/oncology.

Allogeneic hematopoietic SCT for alpha-mannosidosis: an analysis of 17 patients

C. Klein, J. Tolar, J. Kurtzberg, 2012, Bone Marrow Transplantation.

Outcomes after allogeneic hematopoietic cell transplantation for childhood cerebral adrenoleukodystrophy: the largest single-institution cohort report.

G. Raymond, J. Tolar, J. Eisengart, 2011, Blood.

Childhood Cerebral X-Linked Adrenoleukodystrophy: Diffusion Tensor Imaging Measurements for Prediction of Clinical Outcome after Hematopoietic Stem Cell Transplantation

J. Provenzale, J. Tolar, A. McKinney, 2013, American Journal of Neuroradiology.

A multitask clustering approach for single-cell RNA-seq analysis in Recessive Dystrophic Epidermolysis Bullosa

John R. Garbe, Rui Kuang, Huanan Zhang, 2018, PLoS Comput. Biol..

GSK3β inhibition activates the CDX/HOX pathway and promotes hemogenic endothelial progenitor differentiation from human pluripotent stem cells.

M. Kyba, J. Tolar, M. Toyoda, 2016, Experimental hematology.

Rapid DNA replication origin licensing protects stem cell pluripotency

Beau R. Webber, J. Cook, J. Tolar, 2017, bioRxiv.

DNA methylation of Runx1 regulatory regions correlates with transition from primitive to definitive hematopoietic potential in vitro and in vivo.

Beau R. Webber, M. Kyba, M. Iacovino, 2011, Blood.

Blazar from primitive to definitive hematopoietic potential in vitro and in vivo regulatory regions correlates with transition Runx

Beau R. Webber, M. Kyba, M. Iacovino, 2013 .

The latent human herpesvirus-6A genome specifically integrates in telomeres of human chromosomes in vivo and in vitro

Jesse H. Arbuckle, A. Komaroff, J. Montoya, 2010, Proceedings of the National Academy of Sciences.

Hematopoietic reconstitution by multipotent adult progenitor cells: precursors to long-term hematopoietic stem cells

I. Weissman, J. Tolar, Derrick J. Rossi, 2007, The Journal of experimental medicine.

Block Polymer Micelles Enable CRISPR/Cas9 Ribonucleoprotein Delivery: Physicochemical Properties Affect Packaging Mechanisms and Gene Editing Efficiency

Timothy P. Lodge, Jakub Tolar, Thomas Pengo, 2019, Macromolecules.

Gene editing and its application for hematological diseases

D. Voytas, J. Tolar, Mark J. Osborn, 2016, International Journal of Hematology.

Inside out: regenerative medicine for recessive dystrophic epidermolysis bullosa

J. Wagner, J. Tolar, Mark J. Osborn, 2018, Pediatric Research.

Induced pluripotent stem cells from individuals with recessive dystrophic epidermolysis bullosa.

J. Wagner, J. Tolar, A. Hovnanian, 2011, The Journal of investigative dermatology.

Comparative evaluation of set-level techniques in predictive classification of gene expression samples

Filip Zelezný, Jirí Kléma, Jakub Tolar, 2012, BMC Bioinformatics.

cohort report childhood cerebral adrenoleukodystrophy: the largest single-institution Outcomes after allogeneic hematopoietic cell transplantation for

S. Richard, G. Raymond, J. Tolar, 2011 .

transposon system Sleeping Beauty Stable gene transfer and expression in human primary T cells by the

J. Tolar, B. Levine, C. June, 2012 .

A Functional Bioluminescent Zebrafish Screen for Enhancing Hematopoietic Cell Homing

J. Tolar, B. Blazar, Ashley C. Kramer, 2016, Stem cell reports.

Concise Review: Hitting the Right Spot with Mesenchymal Stromal Cells

Jakub Tolar, Armand Keating, J. Tolar, 2010, Stem cells.

Transplacental transfer of small-cell carcinoma of the lung.

J. Tolar, J. Neglia, J. Coad, 2002, The New England journal of medicine.

Case 4-2008: A pregnant woman with a swollen left breast and dyspnea.

J. Tolar, J. Neglia, 2008, The New England journal of medicine.

Favorable outcome of allogeneic hematopoietic cell transplantation for 8p11 myeloproliferative syndrome associated with BCR‐FGFR1 gene fusion

J. Tolar, J. Neglia, N. Cross, 2012, Pediatric blood & cancer.

ATXN1-CIC Complex Is the Primary Driver of Cerebellar Pathology in Spinocerebellar Ataxia Type 1 through a Gain-of-Function Mechanism

Maxime W. C. Rousseaux, Elizabeth P. Lackey, H. Zoghbi, 2018, Neuron.

Mesenchymal stromal cells in wound healing applications: role of the secretome, targeted delivery and impact on recessive dystrophic epidermolysis bullosa treatment.

J. Tolar, C. Ebens, C. Eide, 2021, Cytotherapy.

Retinoblastoma tumor cell proliferation is negatively associated with an immune gene expression signature and increased immune cells

J. Tolar, Chenchen Xie, Huarui Lu, 2021, Laboratory Investigation.

Program death-1 signaling and regulatory T cells collaborate to resist the function of adoptively transferred cytotoxic T lymphocytes in advanced acute myeloid leukemia.

D. Munn, J. Tolar, B. Levine, 2010, Blood.

Phase I/II Trial of StemRegenin-1 Expanded Umbilical Cord Blood Hematopoietic Stem Cells Supports Testing as a Stand-Alone Graft.

Jakub Tolar, Todd E DeFor, Claudio G Brunstein, 2016, Cell stem cell.

Fludarabine-based conditioning for marrow transplantation from unrelated donors in severe aplastic anemia: early results of a cyclophosphamide dose deescalation study show life-threatening adverse events at predefined cyclophosphamide dose levels.

E. Leifer, H. Deeg, J. Tolar, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

CRISPR/Cas9-Based Lateral Flow and Fluorescence Diagnostics

J. Tolar, C. Steer, B. Blazar, 2021, Bioengineering.

An exploratory analysis of mitochondrial haplotypes and allogeneic hematopoietic cell transplantation outcomes.

J. Wagner, J. Tolar, K. Robien, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Correction of DNA protein kinase deficiency by spliceosome-mediated RNA trans-splicing and sleeping beauty transposon delivery.

M. Kay, J. Tolar, H. Zayed, 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

Effect of stem cell source on outcomes after unrelated donor transplantation in severe aplastic anemia.

J. Fay, H. Deeg, J. Tolar, 2011, Blood.

Lower leukemia relapse in pediatric patients with pulmonary cytolytic thrombi following allogeneic transplant

J. Wagner, J. Tolar, M. MacMillan, 2011, Bone Marrow Transplantation.

Engraftment and Survival Following Hematopoietic Stem Cell Transplantation for Osteopetrosis Using a Reduced Intensity Conditioning Regimen.

J. Tolar, P. Orchard, C. Bonfim, 2006 .

Dyskeratosis Congenita: Low Regimen-Related Toxicity Following Hematopoietic Cell Transplantation (HCT) Using a Reduced Intensity Conditioning Regimen.

J. Wagner, J. Tolar, B. Alter, 2007 .

Cardiac disease in mucopolysaccharidosis type I attributed to catecholaminergic and hemodynamic deficiencies.

J. Tolar, B. Blazar, J. Metzger, 2011, American journal of physiology. Heart and circulatory physiology.

Skeletal muscle contractile function and neuromuscular performance in Zmpste24−/− mice, a murine model of human progeria

J. Tolar, B. Blazar, D. Lowe, 2012, AGE.

Learning meets Sequencing : a Generality Framework for Read-Sets

F. Zelezný, J. Tolar, Karel Jalovec, 2015 .

Cellular Engineering and Disease Modeling with Gene-Editing Nucleases

J. Tolar, Mark J. Osborn, 2016 .

Modeling and rescue of defective blood–brain barrier function of induced brain microvascular endothelial cells from childhood cerebral adrenoleukodystrophy patients

J. Tolar, S. Azarin, A. Armién, 2018, Fluids and Barriers of the CNS.

Preclinical testing of anti-human CD28 Fab' antibody in a novel nonhuman primate (NHP) small animal rodent model of xenogenic graft-versus-host disease (GVHD).

J. Tolar, B. Blazar, V. Tkachev, 2016, Transplantation.

Interrogation of RDEB epidermal allografts after BMT reveals co-expression of collagen VII and keratin 15 with proinflammatory immune cells and fibroblasts.

J. Tolar, C. Ebens, C. Eide, 2022, The Journal of investigative dermatology.

Montagna Symposium 2017-Precision Dermatology: Next Generation Prevention, Diagnosis, and Treatment.

J. Tolar, J. McGrath, A. Paller, 2018, The Journal of investigative dermatology.

Neither Donor nor Recipient Mitochondrial Haplotypes Are Associated with Unrelated Donor Transplant Outcomes: A Validation Study from the CIBMTR.

Lara E Sucheston-Campbell, Lara E. Sucheston-Campbell, K. Beckman, 2021, Transplantation and cellular therapy.

TP53 Modulates Oxidative Stress in Gata1+ Erythroid Cells

J. Tolar, Ying Zhang, Ashley C. Kramer, 2017, Stem cell reports.

Allogeneic blood and bone marrow cells for the treatment of severe epidermolysis bullosa: repair of the extracellular matrix

J. Wagner, J. Tolar, 2013, The Lancet.

Stromal cell-derived factor-1 and hematopoietic cell homing in an adult zebrafish model of hematopoietic cell transplantation.

L. Zon, T. Bowman, J. Tolar, 2011, Blood.

Incidence of intracranial germ cell tumors by race in the United States, 1992–2010

J. Tolar, J. Ross, J. Poynter, 2014, Journal of Neuro-Oncology.

CRISPR/Cas9-based genetic correction for recessive dystrophic epidermolysis bullosa

Beau R. Webber, J. Tolar, C. Eide, 2016, npj Regenerative Medicine.

CRISPR/Cas9 Targeted Gene Editing and Cellular Engineering in Fanconi Anemia.

Beau R. Webber, J. Wagner, J. Tolar, 2016, Stem cells and development.

Sickle cell and silent spleen.

J. Tolar, 2015, Blood.

TALEN-based gene correction for epidermolysis bullosa.

Christof von Kalle, Jakub Tolar, Richard Gabriel, 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

Genome-wide Specificity of Highly Efficient TALENs and CRISPR/Cas9 for T Cell Receptor Modification

Christof von Kalle, Jakub Tolar, Richard Gabriel, 2017, Molecular therapy. Methods & clinical development.

Translating Genome Engineering to Survival

J. Tolar, 2015 .

GENE THERAPY FOR HUMAN DISEASE: CLINICAL ADVANCES AND CHALLENGES

J. Tolar, 2013 .

Myelin and Lipid Composition of the Corpus Callosum in Mucopolysaccharidosis Type I Mice.

D. Elashoff, J. Tolar, J. Cooper, 2020, Lipids.

Targeting of the CNS in MPS-IH Using a Nonviral Transferrin-α-l-iduronidase Fusion Gene Product.

J. Tolar, B. Blazar, Mark J. Osborn, 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

Potential of Systemic Allogeneic Mesenchymal Stromal Cell Therapy for Children with Recessive Dystrophic Epidermolysis Bullosa.

J. Tolar, J. McGrath, P. Veys, 2015, The Journal of investigative dermatology.

Circulating anticoagulant glycosaminoglycans in mucopolysaccharidosis type I

J. Tolar, N. Key, B. Blazar, 2008, Journal of thrombosis and haemostasis : JTH.

Hip Dysplasia in Patients With Hurler Syndrome (Mucopolysaccharidosis Type 1H)

J. Tolar, P. Orchard, L. Polgreen, 2013, Journal of pediatric orthopedics.

Targeting of the CNS in MPS-IH using a nonviral transferrin-alpha-L-iduronidase fusion gene product.

J. Tolar, B. Blazar, Mark J. Osborn, 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

Minicircle DNA-based gene therapy coupled with immune modulation permits long-term expression of α-L-iduronidase in mice with mucopolysaccharidosis type I.

G. Freeman, M. Kay, J. Tolar, 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

A picornaviral 2A-like sequence-based tricistronic vector allowing for high-level therapeutic gene expression coupled to a dual-reporter system.

J. Tolar, R. McIvor, A. Wilber, 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

Pericardial effusion after pediatric hematopoietic cell transplant

J. Steinberger, J. Tolar, M. Verneris, 2013, Pediatric transplantation.

Human CD19-Targeted Mouse T Cells Induce B Cell Aplasia and Toxicity in Human CD19 Transgenic Mice.

S. Furlan, J. Tolar, Y. Refaeli, 2018, Molecular therapy : the journal of the American Society of Gene Therapy.

Management of severe epidermolysis bullosa by haematopoietic transplant: principles, perspectives and pitfalls

J. Wagner, J. Tolar, 2012, Experimental dermatology.

Immune tolerance of allogeneic haematopoietic cell transplantation supports donor epidermal grafting of recessive dystrophic epidermolysis bullosa chronic wounds *

J. Tolar, J. McGrath, C. Ebens, 2020, The British journal of dermatology.

Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.

Avis J. Thomas, J. Wagner, J. Tolar, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

On Medawar's ‘Actively acquired tolerance of foreign cells’

J. Tolar, J. McGrath, Simona Tolarova, 2014, Experimental dermatology.

Base editor correction of COL7A1 in recessive dystrophic epidermolysis bullosa patient-derived fibroblasts and iPSCs.

David R. Liu, Gregory A. Newby, Beau R. Webber, 2020, Journal of Investigative Dermatology.

PAX7 Targets, CD54, Integrin α9β1, and SDC2, Allow Isolation of Human ESC/iPSC-Derived Myogenic Progenitors.

R. Stewart, R. Perlingeiro, J. Thomson, 2017, Cell reports.

Granulocyte colony-stimulating factor mobilized CFU-F can be found in the peripheral blood but have limited expansion potential

J. Tolar, P. Orchard, T. Lund, 2008, Haematologica.

Future applications of 3D bioprinting: A promising technology for treating recessive dystrophic epidermolysis bullosa

J. Tolar, C. Eide, W. C. Miller, 2021, Experimental dermatology.

miR-29 Regulates Type VII Collagen in Recessive Dystrophic Epidermolysis Bullosa.

J. Tolar, R. McElmurry, W. Mathews, 2016, The Journal of investigative dermatology.

Augmentation of cutaneous wound healing by pharmacologic mobilization of endogenous bone marrow stem cells.

J. Tolar, J. McGrath, 2014, The Journal of investigative dermatology.

Modeling and rescue of defective blood–brain barrier function of induced brain microvascular endothelial cells from childhood cerebral adrenoleukodystrophy patients

Samira M. Azarin, J. Tolar, F. Bates, 2018, Fluids and Barriers of the CNS.

Molecular Additives Significantly Enhance Glycopolymer-Mediated Transfection of Large Plasmids and Functional CRISPR-Cas9 Transcription Activation Ex Vivo in Primary Human Fibroblasts and Induced Pluripotent Stem Cells.

J. Tolar, T. Reineke, W. S. Boyle, 2018, Bioconjugate chemistry.

sdf1 Expression Reveals a Source of Perivascular‐Derived Mesenchymal Stem Cells in Zebrafish

J. Tolar, D. Lidke, B. Blazar, 2014, Stem cells.

Fludarabine modulates expression of type VII collagen during haematopoietic stem cell transplantation for recessive dystrophic epidermolysis bullosa *

J. Tolar, W. Mathews, D. Muldoon, 2020, The British journal of dermatology.

Safety and early efficacy outcomes for lentiviral fibroblast gene therapy in recessive dystrophic epidermolysis bullosa.

F. Reid, J. Tolar, M. del Río, 2019, JCI insight.

Reliability and validity of the instrument for scoring clinical outcomes of research for epidermolysis bullosa (iscorEB)

D. Fairclough, J. Tolar, J. Feinstein, 2018, The British journal of dermatology.

Reliability and Validity of iscorEB ( Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa ) Short title : Reliability and Construct Validity of iscorEB

D. Fairclough, J. Tolar, J. Feinstein, 2018 .

The evolving microenvironment of the human hepatocyte: Healthy vs. cirrhotic liver vs. isolated cells.

J. Tolar, J. Kim, T. Pruett, 2020, Tissue & cell.

Leukotriene-receptor inhibition for the treatment of systemic mastocytosis.

J. Tolar, J. Neglia, W. Tope, 2004, New England Journal of Medicine.

Pre-transplant risk factors affecting outcome in Hurler syndrome

J. Wagner, J. Tolar, B. Blazar, 2010, Bone Marrow Transplantation.

CRISPR/Cas9-Mediated Correction of the FANCD1 Gene in Primary Patient Cells

Beau R. Webber, J. Tolar, C. Kim, 2017, International journal of molecular sciences.

Comparative Evaluation of Set-Level Techniques in Microarray Classification

Filip Zelezný, Jirí Kléma, Jakub Tolar, 2011, ISBRA.

Integrating Multiple-Platform Expression Data through Gene Set Features

Filip Zelezný, Jirí Kléma, Jakub Tolar, 2009, ISBRA.

Prediction of DNA-binding proteins from relational features

Filip Železný, Jakub Tolar, Andrea Szabóová, 2012, Proteome Science.

Intravenous 6‐mercaptopurine decreases salvage after relapse in childhood acute lymphoblastic leukemia: A report from the Children's Cancer Group study CCG 1922

J. Tolar, H. Sather, B. Bostrom, 2005, Pediatric blood & cancer.

Reprogramming of Human Hepatic Non‐Parenchymal Cells: Step‐by‐Step Protocol

J. Tolar, T. Pruett, V. Kirchner, 2020 .

Regenerative Solutions for Inherited Diseases

J. Tolar, 2018, Clinical pharmacology and therapeutics.

Lactic acidosis and hypoglycemia with ALL relapse following engrafted bone marrow transplant

J. Tolar, A. Moran, M. Mauer, 2009, Pediatric Blood & Cancer.

Genes and compounds that increase type VII collagen expression as potential treatments for dystrophic epidermolysis bullosa

F. W. Albert, J. Tolar, Weili Chen, 2022, Experimental dermatology.

Bacterial meningitis from Rothia mucilaginosa in patients with malignancy or undergoing hematopoietic stem cell transplantation

J. Tolar, M. Schleiss, P. Ferrieri, 2008, Pediatric blood & cancer.

Acid sphingomyelinase deficiency does not protect from graft-versus-host disease in transplant recipients with Niemann-Pick disease.

J. Tolar, B. Blazar, P. Orchard, 2010, Blood.

A novel method for KIR-ligand typing by pyrosequencing to predict NK cell alloreactivity.

Harriet Noreen, Bruce R. Blazar, Jakub Tolar, 2005, Clinical immunology.

Fast, Efficient, and Gentle Transfection of Human Adherent Cells in Suspension.

Kevin D Dorfman, Jakub Tolar, Pranav Agrawal, 2016, ACS applied materials & interfaces.

Mesenchymal stromal cells inhibit murine syngeneic anti-tumor immune responses by attenuating inflammation and reorganizing the tumor microenvironment

J. Tolar, J. Modiano, C. Forster, 2015, Cancer Immunology, Immunotherapy.

Engineering Human Cells Expressing CRISPR/Cas9-Synergistic Activation Mediators for Recombinant Protein Production

J. Tolar, Mark J. Osborn, J. Bingham, 2023, International journal of molecular sciences.

Engineering CRISPR/Cas9 for Multiplexed Recombinant Coagulation Factor Production

J. Tolar, Mark J. Osborn, J. Bingham, 2022, International journal of molecular sciences.

Cerebrospinal Fluid Matrix Metalloproteinases Are Elevated in Cerebral Adrenoleukodystrophy and Correlate with MRI Severity and Neurologic Dysfunction

G. Raymond, J. Tolar, D. Nascene, 2012, PloS one.

CRISPR/Cas9-Based Cellular Engineering for Targeted Gene Overexpression

Beau R. Webber, J. Tolar, C. Eide, 2018, International journal of molecular sciences.

ABCB5+ mesenchymal stromal cells facilitate complete and durable wound closure in recessive dystrophic epidermolysis bullosa.

J. Tolar, Silvia Fluhr, Cristina Daniele, 2023, Cytotherapy.

Reinventing mesenchymal stromal cells.

J. Tolar, M. Tolar, 2012, Cytotherapy.

Derivation and High Engraftment of Patient-Specific Cardiomyocyte Sheet Using Induced Pluripotent Stem Cells Generated From Adult Cardiac Fibroblast

M. Kyba, Liying Zhang, Jianyi(Jay) Zhang, 2015, Circulation. Heart failure.

The three-body problem of therapy with induced pluripotent stem cells

J. Tolar, J. McGrath, 2015, Genome Medicine.

Cerebral Spinal Fluid levels of Cytokines are elevated in Patients with Metachromatic Leukodystrophy

G. Raymond, J. Tolar, P. Orchard, 2016, Scientific Reports.

Sleeping Beauty‐mediated correction of Fanconi anemia type C

J. Tolar, K. Clark, P. Hackett, 2011, The journal of gene medicine.

Angiotensin receptor blockade mediated amelioration of mucopolysaccharidosis type I cardiac and craniofacial pathology

Beau R. Webber, B. Hallgrímsson, J. Tolar, 2017, Journal of Inherited Metabolic Disease.

CD16-IL15-CD33 Trispecific Killer Engager (TriKE) Overcomes Cancer-Induced Immune Suppression and Induces Natural Killer Cell-Mediated Control of MDS and AML Via Enhanced Killing Kinetics

J. Tolar, Jeffrey S. Miller, S. Spellman, 2016 .

Trispecific Killer Engagers (TriKEs) that contain IL-15 to make NK cells antigen specific and to sustain their persistence and expansion

J. Tolar, Bin Zhang, Jeffrey S. Miller, 2015 .

Rapid DNA replication origin licensing protects stem cell pluripotency

Beau R. Webber, J. Cook, J. Tolar, 2017, bioRxiv.

Phage-assisted evolution and protein engineering yield compact, efficient prime editors

Jordan L. Doman, J. Tolar, Aditya Raguram, 2023, Cell.

Relational Subgroup Discovery for Descriptive Analysis of Microarray Data

Nada Lavrac, Igor Trajkovski, Filip Zelezný, 2006, CompLife.

Relational Descriptive Analysis of Gene Expression Data

Nada Lavrac, Igor Trajkovski, Filip Zelezný, 2006, STAIRS.

Phage-assisted evolution and protein engineering yield compact, efficient prime editors

Jordan L. Doman, J. Tolar, Aditya Raguram, 2023, Cell.

Revertant mosaic fibroblasts in recessive dystrophic epidermolysis bullosa

J. Tolar, D. Keene, C. Eide, 2019, The British journal of dermatology.

Oral 6-mercaptopurine protects against fatal relapses in childhood acute lymphoblastic leukemia: a report from the Children's Cancer Group study CCG 1922

J. Tolar, H. Sather, B. Bostrom, 2000 .

Acute polyosteal osteomyelitis in a patient with congenital ichthyosis and acute lymphoblastic leukemia.

J. Tolar, C. Moertel, G. Kravitz, 2001, The Pediatric infectious disease journal.

Clinical trial of ABCB5 + mesenchymal stem cells for recessive dystrophic epidermolysis bullosa

J. Tolar, C. Ebens, A. Hovnanian, 2021 .

The individual (single patient) IND for inborn errors of metabolism.

J. Tolar, P. Dickson, 2015, Molecular Genetics and Metabolism.

J. Tolar, B. Blazar, P. Orchard, 2009, The Journal of heart valve disease.

Sleeping Beauty‐mediated correction of Fanconi anemia type C

J. Tolar, K. Clark, P. Hackett, 2011, The journal of gene medicine.

Evaluation of TCR Gene Editing Achieved by TALENs, CRISPR/Cas9, and megaTAL Nucleases.

Beau R. Webber, C. von Kalle, D. Voytas, 2016, Molecular therapy : the journal of the American Society of Gene Therapy.

Depletion of endogenous tumor-associated regulatory T cells improves the efficacy of adoptive cytotoxic T-cell immunotherapy in murine acute myeloid leukemia.

D. Munn, J. Tolar, B. Levine, 2009, Blood.

A novel explanation of corneal clouding in a bone marrow transplant-treated patient with Hurler syndrome.

J. Tolar, D. Hardten, L. McLoon, 2016, Experimental eye research.

Prevention of acute GVHD disease using an orthogonal IL-2/IL-2Rβ system to selectively expand regulatory T-cells in vivo.

J. Tolar, C. Eide, R. Negrin, 2022, Blood.

The latent human herpesvirus-6A genome specifically integrates in telomeres of human chromosomes in vivo and in vitro

Jesse H. Arbuckle, A. Komaroff, J. Montoya, 2010, Proceedings of the National Academy of Sciences.

Management of severe epidermolysis bullosa by haematopoietic transplant: principles, perspectives and pitfalls

J. Wagner, J. Tolar, J. Wagner, 2012, Experimental dermatology.

J. Wagner, J. Tolar, S. Savage, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Pharmacokinetics of Clofarabine in Patients With High‐Risk Inherited Metabolic Disorders Undergoing Brain‐Sparing Hematopoietic Cell Transplantation

J. Tolar, P. Orchard, Jiayin Huang, 2011, Journal of clinical pharmacology.

Transplant outcomes in leukodystrophies.

J. Tolar, P. Orchard, 2010, Seminars in hematology.

Toxic Epidermal Necrolysis in Recessive Dystrophic Epidermolysis Bullosa following Bone Marrow Transplantation.

J. Tolar, K. Hook, D. Sajic, 2016, The Journal of pediatrics.

A comparative evaluation of gene set analysis techniques in predictive classification of expression samples

Filip Zelezny, Jakub Tolar, Matej Holec, 2010, BIOINFORMATICS 2010.